Toshihiro Ona
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Toshihiro Ona has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Nobuo Yoshizawa
Utsunomiya University
8 shared publications - Shinso Yokota
Utsunomiya University
8 shared publications - Jyunichi Ohshima
Utsunomiya University
5 shared publications - Teruyuki Seino
Institute for Environmental Management Technology
5 shared publications - Yasuo Kojima
Hokkaido University
5 shared publications - Takayuki Okayama
Division of Natural Resources and Ecomaterials, Institute of Agriculture, Tokyo University of Agriculture and Technology
4 shared publications
Latest Publications
- Open Access
- 1 November 2022
- Published by MDPI AG in Medical Sciences Forum
- Vol. 14 (1) , 63
Rapid and Synchronized Dormancy-Breaking Jumbo Leek Bulb Inhibits Postprandial Carbohydrate Degradation and Absorption to Be Assumed Preprandial Ingestion
In order to prevent obesity and diabetes, it is important to avoid overeating, especially carbohydrates. Therefore, we evaluated the effect of taking a jumbo leek bulb before a meal on the decomposition and absorption inhibition of carbohydrates after a meal. In this case, we used a product that had been heat-treated after rapid and synchronized dormancy-breaking (RSDB) had been used to promote phase transition of its content, and we investigated by decreasing two enzyme activities, namely pancreatic α-amylase and α-glucosidase, and reported the results. In the case of pancreatic α-amylase, the untreated (heated and lyophilized) without RSDB showed a 6.5% inhibition of enzyme activity when compared to the control. In contrast, the RSDB inhibited it more effectively by 12.5%. In the case of α-glucosidase, the untreated group had 9.1% inhibition of enzyme activity, whereas the RSDB treatment had 14.6% inhibition, which was about 1.6 times more effective than the untreated group. Thus, the RSDB jumbo leek bulb, when taken before a meal, was found to inhibit postprandial carbohydrate decomposition and absorption (postprandial hyperglycemia prevention effect). It is possible that the inulin in the jumbo leek has an inhibitory effect on glucose absorption by wrapping the carbohydrates, but the RSDB treatment may have accelerated the effect. Furthermore, organosulfur compounds are expected to enhance insulin production and efficiency. In conclusion, the high efficacy of the RSDB jumbo leek in suppressing postprandial carbohydrate degradation and absorption was observed in a model experiment. The RSDB jumbo leek bulb is expected to be effective in preventing obesity and diabetes.
- 1 November 2022
- Published by MDPI AG in Medical Sciences Forum
- Vol. 14 (1) , 63
Open AccessRapid and Synchronized Dormancy-Breaking Jumbo Leek Bulb Inhibits Postprandial Carbohydrate Degradation and Absorption to Be Assumed Preprandial Ingestion
In order to prevent obesity and diabetes, it is important to avoid overeating, especially carbohydrates. Therefore, we evaluated the effect of taking a jumbo leek bulb before a meal on the decomposition and absorption inhibition of carbohydrates after a meal. In this case, we used a product that had been heat-treated after rapid and synchronized dormancy-breaking (RSDB) had been used to promote phase transition of its content, and we investigated by decreasing two enzyme activities, namely pancreatic α-amylase and α-glucosidase, and reported the results. In the case of pancreatic α-amylase, the untreated (heated and lyophilized) without RSDB showed a 6.5% inhibition of enzyme activity when compared to the control. In contrast, the RSDB inhibited it more effectively by 12.5%. In the case of α-glucosidase, the untreated group had 9.1% inhibition of enzyme activity, whereas the RSDB treatment had 14.6% inhibition, which was about 1.6 times more effective than the untreated group. Thus, the RSDB jumbo leek bulb, when taken before a meal, was found to inhibit postprandial carbohydrate decomposition and absorption (postprandial hyperglycemia prevention effect). It is possible that the inulin in the jumbo leek has an inhibitory effect on glucose absorption by wrapping the carbohydrates, but the RSDB treatment may have accelerated the effect. Furthermore, organosulfur compounds are expected to enhance insulin production and efficiency. In conclusion, the high efficacy of the RSDB jumbo leek in suppressing postprandial carbohydrate degradation and absorption was observed in a model experiment. The RSDB jumbo leek bulb is expected to be effective in preventing obesity and diabetes.
- 1 October 2018
- Published by Springer Nature in Analytical Sciences
- Vol. 34 (10) , 1189-1194
One Hour In Vivo-like Phenotypic Screening System for Anti-cancer Drugs Using a High Precision Surface Plasmon Resonance Device
In anti-cancer drug (candidate) screening, there is the need for evaluation at physiological concentrations similar to in vivo. This is often performed by three-dimensionally (3D) cultured cells; however, it requires a long culture period of 2 - 4 weeks with tedious experimental procedures. Here, we report on a high precision surface plasmon resonance (HP-SPR)-3D system. We developed the system with average fluctuation of 50 ndeg s(-1) using two-dimensionally cultured cells attached onto a sensor chip by applying collagen on the top to change their activity into in vivo-like conditions without cell division. It allowed in vivo-like phenotypic screening for anti-cancer drugs within 1 h of drug addition. The data were collected as the stable linear signal change parts for at least 5 min after 25 min following drug addition. The results provided compatibility to clinically related chemosensitivity test for anti-cancer (P <0.001) using two cell lines of pancreatic cancer and three anti-cancer drugs to represent differences in individual gene expression and drug mode of action.
- 1 October 2018
- Published by Springer Nature in Analytical Sciences
- Vol. 34 (10) , 1189-1194
One Hour In Vivo-like Phenotypic Screening System for Anti-cancer Drugs Using a High Precision Surface Plasmon Resonance Device
In anti-cancer drug (candidate) screening, there is the need for evaluation at physiological concentrations similar to in vivo. This is often performed by three-dimensionally (3D) cultured cells; however, it requires a long culture period of 2 - 4 weeks with tedious experimental procedures. Here, we report on a high precision surface plasmon resonance (HP-SPR)-3D system. We developed the system with average fluctuation of 50 ndeg s(-1) using two-dimensionally cultured cells attached onto a sensor chip by applying collagen on the top to change their activity into in vivo-like conditions without cell division. It allowed in vivo-like phenotypic screening for anti-cancer drugs within 1 h of drug addition. The data were collected as the stable linear signal change parts for at least 5 min after 25 min following drug addition. The results provided compatibility to clinically related chemosensitivity test for anti-cancer (P <0.001) using two cell lines of pancreatic cancer and three anti-cancer drugs to represent differences in individual gene expression and drug mode of action.
- 5 October 2010
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 398 (6) , 2505-2533
Advanced dynamic monitoring of cellular status using label-free and non-invasive cell-based sensing technology for the prediction of anticancer drug efficacy
Quantitative evaluation of anticancer drug efficacy using in vitro cell-based assays is useful for cancer patients, particularly those who show unconventional cancer development. Nevertheless, conventional chemosensitivity testing often requires widely used labeling agents and time-consuming laboratory procedures that provide low reliability. Label-free non-invasive cell-based assays are desired for dynamic monitoring of cellular status. This critical review first describes conventional chemosensitivity testing and then advanced label-free cell-based technology used to screen anticancer drugs through dynamic monitoring of cellular status, focusing on dosage and the use of drug-resistant cancer cells. Results from label-free cell-based approaches are compared with those of conventional chemosensitivity testing. The cellular statuses, addressed in terms of respective mechanisms and disadvantages, are extracellular fluxes of proton (H+), O2, and anticancer drugs, cell morphology changes, cell–environment interaction, and mitochondrial membrane potential. Finally, a cell-based systems outlook is presented. This paper represents a step toward efficient and accurate initial screening of anticancer drugs and development of compounds and their combined use to achieve pharmacodynamic and pharmacokinetic interactions, and chemotherapy evaluation of particular anticancer drugs for individual patients.
- 5 October 2010
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 398 (6) , 2505-2533
Advanced dynamic monitoring of cellular status using label-free and non-invasive cell-based sensing technology for the prediction of anticancer drug efficacy
Quantitative evaluation of anticancer drug efficacy using in vitro cell-based assays is useful for cancer patients, particularly those who show unconventional cancer development. Nevertheless, conventional chemosensitivity testing often requires widely used labeling agents and time-consuming laboratory procedures that provide low reliability. Label-free non-invasive cell-based assays are desired for dynamic monitoring of cellular status. This critical review first describes conventional chemosensitivity testing and then advanced label-free cell-based technology used to screen anticancer drugs through dynamic monitoring of cellular status, focusing on dosage and the use of drug-resistant cancer cells. Results from label-free cell-based approaches are compared with those of conventional chemosensitivity testing. The cellular statuses, addressed in terms of respective mechanisms and disadvantages, are extracellular fluxes of proton (H+), O2, and anticancer drugs, cell morphology changes, cell–environment interaction, and mitochondrial membrane potential. Finally, a cell-based systems outlook is presented. This paper represents a step toward efficient and accurate initial screening of anticancer drugs and development of compounds and their combined use to achieve pharmacodynamic and pharmacokinetic interactions, and chemotherapy evaluation of particular anticancer drugs for individual patients.
- Open Access
- 10 May 2010
- Published by Springer Nature in Analytical Sciences
- Vol. 26 (5) , 529-534
Development of Signaling Echo Method for Cell-based Quantitative Efficacy Evaluation of Anti-cancer Drugs in Apoptosis without Drug Presence Using High-precision Surface Plasmon Resonance Sensing
We propose a rapid and label-free quantitative evaluation of anti-cancer drug efficacy in apoptosis using live cancer cells cultured on a sensor chip. The resultant custom-made, high-precision surface plasmon resonance (SPR) sensor monitors the inner mitochondrial membrane’s potential change (ΔΨm). For trans-membrane anti-cancer drugs to be effective, continuous potential changes arising from the crossing of the membrane by the drug of interest prevent ΔΨm monitoring. Herein, we report on a novel signaling echo method that avoids this disturbance; the cancer cells are incubated with a specific anti-cancer drug, with subsequent removal of the drug before SPR measurements. The cell reaction without any drug was monitored as the differential SPR angle rate of change for 10 min from 30 min after a sensor chip was set on a prism. The cell reaction after 60 min pre-incubation with a drug was significantly related to the conventional cell viability after 48 h (P <0.001).
- 10 May 2010
- Published by Springer Nature in Analytical Sciences
- Vol. 26 (5) , 529-534
Open AccessDevelopment of Signaling Echo Method for Cell-based Quantitative Efficacy Evaluation of Anti-cancer Drugs in Apoptosis without Drug Presence Using High-precision Surface Plasmon Resonance Sensing
We propose a rapid and label-free quantitative evaluation of anti-cancer drug efficacy in apoptosis using live cancer cells cultured on a sensor chip. The resultant custom-made, high-precision surface plasmon resonance (SPR) sensor monitors the inner mitochondrial membrane’s potential change (ΔΨm). For trans-membrane anti-cancer drugs to be effective, continuous potential changes arising from the crossing of the membrane by the drug of interest prevent ΔΨm monitoring. Herein, we report on a novel signaling echo method that avoids this disturbance; the cancer cells are incubated with a specific anti-cancer drug, with subsequent removal of the drug before SPR measurements. The cell reaction without any drug was monitored as the differential SPR angle rate of change for 10 min from 30 min after a sensor chip was set on a prism. The cell reaction after 60 min pre-incubation with a drug was significantly related to the conventional cell viability after 48 h (P <0.001).
- 1 January 2009
- Published by Society of Fiber Science and Technology Japan in Sen'i Gakkaishi
- Vol. 65 (8) , 212-217
Preparation of Cellobiose-conjugated Polyacrylamide and its Interaction with a Cellulose Matrix for Papermaking Application
- 1 January 2009
- Published by Society of Fiber Science and Technology Japan in Sen'i Gakkaishi
- Vol. 65 (8) , 212-217
Preparation of Cellobiose-conjugated Polyacrylamide and its Interaction with a Cellulose Matrix for Papermaking Application
- 15 May 2008
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 391 (5) , 1889-1897
Rapid and quantitative method for evaluating the personal therapeutic potential of cancer drugs
An in vitro, rapid, and quantitative cell-based assay is needed to predict the efficacy of cancer drugs in individual patients, because a cancer patient may have unconventional aspects of tumor development. Here we report a rapid and label-free quantitative method for verifying apoptosis in living cancer cells cultured on a sensor chip with a newly developed high-precision surface plasmon resonance (SPR) sensor. The time-course cell reaction was monitored as the SPR angle change rate for 5 min during a 35-min cell culture of pancreatic cancer lines with a drug. The time-course cell reaction was significantly related to cell viability counted after 48 h as assessed by caspase-3 activity assay of apoptosis. Furthermore, the detected SPR signal was derived from the decrease in inner mitochondrial membrane potential. The results obtained are universally valid for various cancer drugs mediating apoptosis through different cell-signaling pathways and even for combined use in various pancreatic cancer cell lines. This system can be applied in a clinical setting to evaluate the personal therapeutic potential of drugs including pharmacodynamic interactions.
- 15 May 2008
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 391 (5) , 1889-1897
Rapid and quantitative method for evaluating the personal therapeutic potential of cancer drugs
An in vitro, rapid, and quantitative cell-based assay is needed to predict the efficacy of cancer drugs in individual patients, because a cancer patient may have unconventional aspects of tumor development. Here we report a rapid and label-free quantitative method for verifying apoptosis in living cancer cells cultured on a sensor chip with a newly developed high-precision surface plasmon resonance (SPR) sensor. The time-course cell reaction was monitored as the SPR angle change rate for 5 min during a 35-min cell culture of pancreatic cancer lines with a drug. The time-course cell reaction was significantly related to cell viability counted after 48 h as assessed by caspase-3 activity assay of apoptosis. Furthermore, the detected SPR signal was derived from the decrease in inner mitochondrial membrane potential. The results obtained are universally valid for various cancer drugs mediating apoptosis through different cell-signaling pathways and even for combined use in various pancreatic cancer cell lines. This system can be applied in a clinical setting to evaluate the personal therapeutic potential of drugs including pharmacodynamic interactions.
- 1 January 2006
- Published by Japan Technical Association of the Pulp and Paper Industry in JAPAN TAPPI JOURNAL
- Vol. 60 (10) , 1539-1546
The 2006 Pan Pacific Conference
2006 Pan Pacific Conference が韓国のソウルで(6月6日~6月9日)Korea TAPPIの主催で開催された。紙パルプ技術協会の代表として,岡山東京農工大教授と豊福専務理事が参加した。Pan Pacific Conferenceは環太平洋の加盟8カ国の技術協会が2年に一度持ち回りで開催する会議で,2004年はオーストラリアのキャンベラで行われた。今回は日本から企業と大学をあわせて8件の発表が行われた。Conferenceでの日本からの発表と注目発表の概要について紹介する。
- 1 January 2006
- Published by Japan Technical Association of the Pulp and Paper Industry in JAPAN TAPPI JOURNAL
- Vol. 60 (10) , 1539-1546
The 2006 Pan Pacific Conference
2006 Pan Pacific Conference が韓国のソウルで(6月6日~6月9日)Korea TAPPIの主催で開催された。紙パルプ技術協会の代表として,岡山東京農工大教授と豊福専務理事が参加した。Pan Pacific Conferenceは環太平洋の加盟8カ国の技術協会が2年に一度持ち回りで開催する会議で,2004年はオーストラリアのキャンベラで行われた。今回は日本から企業と大学をあわせて8件の発表が行われた。Conferenceでの日本からの発表と注目発表の概要について紹介する。
- 1 April 2005
- Published by Springer Nature in Journal of Wood Science
- Vol. 51 (2) , 102-111
Examination of within-tree variations and the heights representing whole-tree values of derived wood properties for quasi-non-destructive breeding of Eucalyptus camaldulensis and Eucalyptus globulus as quality pulpwood
- 1 April 2005
- Published by Springer Nature in Journal of Wood Science
- Vol. 51 (2) , 102-111
Examination of within-tree variations and the heights representing whole-tree values of derived wood properties for quasi-non-destructive breeding of Eucalyptus camaldulensis and Eucalyptus globulus as quality pulpwood
- 20 November 2004
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 380 (7-8) , 958-963
Length determination of vessel elements in tree trunks used for water and nutrient transport by Fourier transform Raman spectroscopy
- 20 November 2004
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 380 (7-8) , 958-963
Length determination of vessel elements in tree trunks used for water and nutrient transport by Fourier transform Raman spectroscopy
- 1 January 2004
- Published by Springer Nature
- p. 52-59
Fiber Properties and Papermaking Potential of Recycled Acacia Pulp
- 1 January 2004
- Published by Springer Nature
- p. 52-59
Fiber Properties and Papermaking Potential of Recycled Acacia Pulp